JPM vs MUFG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MUFG presents a contradictory profile, characterized by a weak Piotroski F-Score of 2/9 indicating deteriorating financial health trends, despite trading near its Graham Number of $16.78. While the intrinsic value of $21.25 suggests long-term upside, the current technical trend is bearish (0/100) and insider sentiment is low (40/100). Positive YoY revenue growth (11.7%) and a sustainable dividend payout ratio provide a fundamental floor, but the low health score and negative Q/Q EPS growth (-31%) necessitate a cautious approach. The stock is currently a value play with significant underlying health red flags.
Compare Another Pair
Related Comparisons
JPM vs MUFG: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Mitsubishi UFJ Financial Group, Inc. (MUFG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.